Literature DB >> 23759756

Prevalence, awareness, treatment and control of hypertension in elderly Chinese.

Chang-Sheng Sheng1, Ming Liu, Yuan-Yuan Kang, Fang-Fei Wei, Lu Zhang, Ge-Le Li, Qian Dong, Qi-Fang Huang, Yan Li, Ji-Guang Wang.   

Abstract

We studied the prevalence, awareness, treatment and control of hypertension in an elderly Chinese population. The study subjects (age ≥60 years) were recruited from a suburban town of Shanghai from 2006 to 2008. We administered a standardized questionnaire to collect information on medical history, the use of medications and lifestyle. We measured blood pressure three times consecutively using a validated Omron 7051 oscillometric device (Kyoto, Japan) after the subjects had rested for at least 5 min in the sitting position. We defined hypertension as a blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic or as the use of antihypertensive drugs. The 3949 participants (mean age of 68.3 years) included 2185 (55.3%) women, 182 (4.6%) obese subjects (body mass index ≥30 kg m(-2)) and 366 (9.3%) diabetic patients. The prevalence of hypertension was 59.4%. In the 2345 hypertensive patients, the awareness, treatment and control (<140/90 mm Hg) rates were 72.5%, 65.8% and 24.4%, respectively. In the 1542 treated hypertensive patients, 1196 (77.6%) used fixed-dose combinations of thiazide and reserpine or clonidine (n=1157, 75.0%) or of an angiotensin receptor blocker and hydrochlorothiazide (n=1) or free combinations (n=38, 2.5%), and 346 (22.4%) used a monotherapy of short-acting calcium channel blockers (n=217, 14.1%) or other classes of antihypertensive drugs (n=129, 8.3%). The corresponding control rates were 37.3% and 36.4%, respectively. In a stepwise logistic regression, the risk of uncontrolled hypertension was higher with older age (+10 years, odds ratio (OR) 1.19, P=0.03), female sex (OR 1.40, P=0.01), obesity (OR 2.35, P=0.0002) and heavy drinking (≥300 g per week, OR 2.18, P=0.0007). In conclusion, in elderly Chinese, the prevalence of hypertension is high. In spite of reasonably high awareness and treatment rates, the control rate remains low, most likely due to an unhealthy lifestyle and the underuse and/or underdose of antihypertensive drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23759756     DOI: 10.1038/hr.2013.57

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  32 in total

Review 1.  Unique approaches to hypertension control in China.

Authors:  Ji-Guang Wang
Journal:  Ann Transl Med       Date:  2018-08

2.  Difference in the risk profiles of carotid-femoral pulse wave velocity: results from two community-based studies in China and Sweden.

Authors:  Qian-Hui Guo; Iram Faqir Muhammad; Yan Borné; Chang-Sheng Sheng; Margaretha Persson; Ji-Guang Wang; Gunnar Engström; Yan Li; Peter M Nilsson
Journal:  J Hum Hypertens       Date:  2019-01-15       Impact factor: 3.012

3.  The 2014 hypertension guidelines: implications for patients and practitioners in Asia.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Paolo Verdecchia
Journal:  Heart Asia       Date:  2015-11-24

4.  Combined effect of obesity and low physical performance on the incidence of hypertension in Chinese community-dwelling older population.

Authors:  Yuewen Liu; Yaoxin Chen; Peipei Han; Weibo Ma; Ming Cai; Feng Wang; Jingru Wang; Jinyu Zhang; Wen He; Xiaoyi Zhu; Qi Guo; Ying Yu
Journal:  J Hum Hypertens       Date:  2020-11-18       Impact factor: 3.012

5.  Effect of age stratification on the association between carotid intima-media thickness and cognitive impairment in Chinese hypertensive patients: new insight from the secondary analysis of the China Stroke Primary Prevention Trial (CSPPT).

Authors:  Junpei Li; Ling Guo; Lishun Liu; Chengzhang Liu; Lijing Ye; Yun Song; Genfu Tang; Binyan Wang; Xianhui Qin; Yan Zhang; Jianping Li; Ping Li; Huihui Bao; Yanqing Wu; Xiping Xu; Xiaobin Wang; Yong Huo; Xiao Huang; Xiaoshu Cheng
Journal:  Hypertens Res       Date:  2021-09-07       Impact factor: 3.872

Review 6.  Chinese Hypertension Guidelines.

Authors:  Ji-Guang Wang
Journal:  Pulse (Basel)       Date:  2015-04-29

7.  Impact of new hypertension guidelines on target organ damage screening in a Shanghai community-dwelling population.

Authors:  Qian Wang; Huijuan Chao; Shuping Zheng; Isabella Tan; Mark Butlin; Alberto Avolio; Junli Zuo
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-18       Impact factor: 3.738

8.  Barriers to blood pressure control in China in a large opportunistic screening.

Authors:  Xin Chen; Shao-Kun Xu; Qian-Hui Guo; Zhe Hu; Hong-Yu Wang; Jing Yu; Wei-Hua Li; Guo-Bao Tang; Hai-Feng Zhang; Yan Li; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-09       Impact factor: 3.738

Review 9.  Asian management of hypertension: Current status, home blood pressure, and specific concerns in China.

Authors:  Qian-Hui Guo; Yu-Qing Zhang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-10-17       Impact factor: 3.738

10.  Efficacy and tolerability of initial high vs low doses of S-(-)-amlodipine in hypertension.

Authors:  Qi Chen; Qi-Fang Huang; Yuan-Yuan Kang; Shao-Kun Xu; Chang-Yuan Liu; Yan Li; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-05-30       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.